Examples of using Polyuria in English and their translations into Croatian
{-}
-
Colloquial
-
Ecclesiastic
-
Computer
Polyuria- what is it?
People with a weak orunstable bladder often experience polyuria.
Polyuria Urine flow decreased.
In a clinical trial, very common adverse reactions were polydipsia and polyuria.
As with nocturnal polyuria should take the medication"Minirin"?
With the genitourinary system: cystic enlargement of the ovaries, dysmenorrhoea,thamuria, polyuria, polycyesis.
Polyuria and nicturia are the first signs of disease caused by urinary concentration defect.
As a result of the diuretic action of torasemide, haemoconcentration and, very commonly, polyuria and/or polydipsia are observed.
Polyuria or Pollakiuriaf, Urinary tract infection pyelonephritis and urosepsis have been reported postmarketing.
With the genitourinary system: clouding of urine, impairment of renal function,thamuria/ nocturia, polyuria, decreased libido.
Systemically administered corticosteroids may cause polyuria, polydipsia and polyphagia, particularly during the early stages of therapy.
In a clinical trial,very common adverse reactions were polydipsia(excessive drinking) and polyuria excessive urination.
Polyuria or pollakiuria includes the terms polyuria, pollakiuria, micturition urgency, nocturia, and urine output increased.
Tolvaptan may cause adverse reactions related to water loss such as thirst, polyuria, nocturia, and pollakiuria see section 4.8.
The classic symptoms of diabetes are polyuria(frequent urination), polydipsia(increased thirst), polyphagia(increased hunger), and weight loss.
At excessively high plasma concentrations of magnesium(for example, when a very rapid on/ in, in renal failure): nausea, paraesthesia,vomiting, polyuria.
If your dog is exhibiting extreme polyuria,(excessive urination), higher maintenance fluid rates will be necessary for replacing those being excreted.
The signs and symptoms of an acute overdose can be anticipated to be those of excessive pharmacologic effect:a rise in serum sodium concentration, polyuria, thirst and dehydration/hypovolemia.
The most common side effects with Jinarc(which may affect more than 2 in 10 people)are thirst, polyuria(increase in urine production), nocturia(need to pass urine at night) and pollakiuria increased need to pass urine during the day.
With the genitourinary system: nephrotoxicity oligurija, цilindrurija, proteinuria, tubular disorders, increases in serum creatinine and urea nitrogen, substantial increase ordecrease in urinary frequency, polyuria, thirst.
The pharmacodynamically predictable andmost commonly reported adverse reactions are thirst, polyuria, nocturia, and pollakiuria occurring in approximately 55%, 38%, 29% and 23% of patients, respectively.
The most commonly reported adverse reactions during treatment were hypoglycaemia in combination with insulin or a sulphonylurea,vulvovaginal candidiasis, urinary tract infection, and polyuria or pollakiuria i.e..
This results in increased blood glucose levels andassociated clinical signs such as polyuria(increase in urine volume), polydipsia(increase in water intake) and weight loss.
Nesaharnыy diabetes, severe polyuria, polydipsia after surgery in the pituitary, Primary Bedwetting Urine(only for intranasal administration); for the on/in the introduction-hemophilia a, von Willebrand disease(except type IIb); nocturia.
With the genitourinary system: nephrotoxicity- increase or decrease the frequency of urination, thirst,oliguria or polyuria, the appearance of the precipitate in the urine, increasing the concentration of urea and creatinine in plasma, proteinuria.
The main measure of effectiveness was improvement in control of diabetes 6 weeks after starting treatment, which was determined by improvement of blood sugar measurements and at least one of three clinical signs:bodyweight, polyuria and polydipsia.
Increased urination(including the predefined terms pollakiuria, polyuria, and nocturia) was observed at higher frequencies in patients treated with empagliflozin(empagliflozin 10 mg: 3.4%, empagliflozin 25 mg: 3.2%) compared to placebo 1.0.
Patients treated with any atypical antipsychotic, including INVEGA,should be monitored for symptoms of hyperglycaemia(such as polydipsia, polyuria, polyphagia, and weakness) and patients with diabetes mellitus should be monitored regularly for worsening of glucose control.
As expected fromthe mechanism of action, increased urination(as assessed by PT search including pollakiuria, polyuria, nocturia) was observed at higher frequencies in metformin-treated patients who received empagliflozin 10 mg(3.0%) and empagliflozin 25 mg(2.9%) compared to placebo(1.4%) as add-on to metformin therapy.
Patients treated with any antipsychotic medicines, including Zalasta, should be observed for signs andsymptoms of hyperglycaemia(such as polydipsia, polyuria, polyphagia, and weakness) and patients with diabetes mellitus or with risk factors for diabetes mellitus should be monitored regularly for worsening of glucose control.